Imagem Esquerda
35º Congresso Mineiro de Cardiologia
Imagem Direita
1º Dia - 8/1/26
2º Dia - 7/30/26
3º Dia - 7/31/26

Evidências para uso de beta-bloqueadores em pacientes pós infarto (fases aguda e crônica) Voltar

LAURA JUNQUEIRA CAIXETA CALAZANS FERREIRA

DOENÇA CORONÁRIA CRÔNICA - RICARDO SIMÕES e TARCÍSIO CESTARI GROSSI

Artigo Autor(es) Referência
Beta-Blocker Therapy After Myocardial Infarction. Cataldo Miranda Pilar, Gasevic Danijela, Trin Caroline, Stub Dion, Zoungas Sophia, Kaye David M, Orman Zhomart, Eliakundu Amminadab L, Talic Stella JACC. Advances. 2025 Mar; 4(Mar):101582. doi: 10.1016/j.jacadv.2024.101582. pii: 101582.
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction. Kristensen Anna Meta Dyrvig, Rossello Xavier, Atar Dan, Yndigegn Troels, Kimura Takeshi, Latini Roberto, Lindahl Bertil, Halvorsen Sigrun, Olsen Michael Hecht, Fuster Valentin, Hofmann Robin, Vikenes Kjell, Maeng Michael, Erlinge David, Pocock Stuart, Karlström Patric, Bakken Arnhild, Lange Theis, Barrabés Jose A, Benatar Jocelyne, Raposeiras-Roubin Sergio, Held Claes, Piepoli Massimo, Fagerland Morten Wang, Holmager Therese, Ozasa Neiko, Prescott Eva Irene Bossano, Munkhaugen John, Jernberg Tomas, Ibanez Borja, The New England journal of medicine. 2025 Nov; doi: 10.1056/NEJMoa2512686. pii: .
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction. Ibanez Borja, Latini Roberto, Rossello Xavier, Dominguez-Rodriguez Alberto, Fernández-Vazquez Felipe, Pelizzoni Valentina, Sánchez Pedro L, Anguita Manuel, Barrabés José A, Raposeiras-Roubín Sergio, Pocock Stuart, Escalera Noemí, Staszewsky Lidia, Pérez-García Carlos Nicolás, Díez-Villanueva Pablo, Pérez-Rivera Jose-Angel, Prada-Delgado Oscar, Owen Ruth, Pizarro Gonzalo, Caldes Onofre, Gómez-Talavera Sandra, Tuñón José, Bianco Matteo, Zarauza Jesus, Vetrano Alfredo, Campos Ana, Martínez-Huertas Susana, Bueno Héctor, Puentes Miguel, Grigis Giulietta, Bonilla-Palomas Juan L, Marco Elvira, González-Juanatey José R, Bangueses Roi, González-Juanatey Carlos, García-Álvarez Ana, Ruiz-García Juan, Carrasquer Anna, García-Rubira Juan C, Pascual-Figal Domingo, Tomás-Querol Carlos, San Román J Alberto, Baratta Pasquale, Agüero Jaume, Martín-Reyes Roberto, Colivicchi Furio, Ortas-Nadal Rosario, Bazal Pablo, Cordero Alberto, Fernández-Ortiz Antonio, Basso Pierangelo, González Eva, Poletti Fabrizio, Bugani Giulia, Debiasio Marzia, Cosmi Deborah, Navazio Alessandro, Bermejo Javier, Tortorella Giovanni, Marini Marco, Botas Javier, de la Torre-Hernández José M, Ottani Filippo, Fuster Valentín, The New England journal of medicine. 2025 Nov; 393(Nov):1889-1900. doi: 10.1056/NEJMoa2504735. pii: .
Reflections on Oral Beta Blocker Therapy and Long-term Outcomes after Myocardial Infarction in Preserved Left Ventricular Function. Yaghoubi Nezhad Reza, Zare Hossein, Abasi Ali Cardiovascular drugs and therapy. 2026 May; doi: 10.1007/s10557-026-07880-9. pii: .
When Randomization Is Not Enough: Divergent Beta-Blocker Trials and the Illusion of Universal Causality. Omerovic Elmir, Råmunddal Truls, Jha Sandeep, Petursson Petur, Skoglundv Kristofer, Rawshani Araz, Redfors Björn European heart journal. Cardiovascular pharmacotherapy. 2026 Jun; doi: 10.1093/ehjcvp/pvag037. pii: pvag037.
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials. Rossello Xavier, Prescott Eva Irene Bossano, Kristensen Anna Meta Dyrvig, Latini Roberto, Fuster Valentin, Fagerland Morten Wang, Pocock Stuart J, Halvorsen Sigrun, Dominguez-Rodriguez Alberto, Holmager Therese Lucia Friis, Sanchez Pedro Luis, Bakken Arnhild, Raposeiras-Roubin Sergio, Jensen Svend Eggert, Kimura Takeshi, Ottani Filippo, Lambrechtsen Jess, Anguita Manuel, Ozasa Neiko, Atar Dan, Ibanez Borja, Munkhaugen John Lancet (London, England). 2025 Sep; 406(Sep):1128-1137. doi: 10.1016/S0140-6736(25)01592-2. pii: S0140-6736(25)01592-2.
Nenhuma revista foi definida para este congresso.